Cargando…

Intraoperative Chemotherapy with a Novel Regimen Improved the Therapeutic Outcomes of Colorectal Cancer

Background: This study sought to evaluate the efficacy of a novel intraoperative chemotherapy (IOC) regimen that consists of hydroxycamptothecin, tumor necrosis factor (TNF), 5-fluorouracil (5-FU), and calcium folinate (CF) on the outcomes of colorectal cancer (CRC). Methods: In total, 551 CRC patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zhihua, Zou, Yifeng, Rong, Yuming, Shi, Xingyuan, Li, Chen, Li, Chao, Tian, Yinghai, Lin, Hongcheng, Liu, Min, Weng, Jinsheng, Liu, Ting, Li, Xiaomei, Lei, Chao, Li, Weipeng, Zhou, Xinke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856593/ https://www.ncbi.nlm.nih.gov/pubmed/31762808 http://dx.doi.org/10.7150/jca.35450

Ejemplares similares

TCR-like antibodies in cancer immunotherapy
por: He, Qinghua, et al.
Publicado: (2019)

Effect and safety of intraoperative intraperitoneal chemotherapy on patients suffering from colorectal cancer
por: Shang, An, et al.
Publicado: (2021)

The Effect of the Intraoperative Blood Loss and Intraoperative Blood Transfusion on the Short-Term Outcomes and Prognosis of Colorectal Cancer: A Propensity Score Matching Analysis
por: Kang, Bing, et al.
Publicado: (2022)

Efficacy and safety of metronomic chemotherapy in maintenance therapy for metastatic colorectal cancer: A systematic review of randomized controlled trials
por: Chen, Li, et al.
Publicado: (2022)

Costs and consequences of different chemotherapy regimens in metastatic colorectal cancer
por: Hale, J P, et al.
Publicado: (2002)

Chemoimmunotherapy in advanced esophageal squamous cell carcinoma: optimizing chemotherapy regimens for immunotherapy combinations
por: Liu, Zhichao, et al.
Publicado: (2022)

Clinical significance of UGT1A1 gene polymorphisms on irinotecan-based regimens as the treatment in metastatic colorectal cancer
por: Li, Minmin, et al.
Publicado: (2014)

Targeting cancers through TCR-peptide/MHC interactions
por: He, Qinghua, et al.
Publicado: (2019)

Clinical Efficacy of Modified Yiwei Shengyang Decoction Combined with FOLFOX4 Chemotherapy Regimen in the Treatment of Advanced Gastric Cancer and Its Effect on Tumor Marker Levels
por: Wu, Hongying, et al.
Publicado: (2022)

Recombinant Newcastle disease virus expressing human IFN‐λ1 (rL‐hIFN‐λ1)‐induced apoptosis of A549 cells is connected to endoplasmic reticulum stress pathways
por: Yan, Yulan, et al.
Publicado: (2018)

Network meta-analysis of the efficacy of first-line chemotherapy regimens in patients with advanced colorectal cancer
por: Wu, Dong-Mei, et al.
Publicado: (2017)

Comparison of hyperthermic intraperitoneal chemotherapy regimens for treatment of peritoneal-metastasized colorectal cancer
por: Spiegelberg, Julia, et al.
Publicado: (2020)

Hsa_circ_0041150 serves as a novel biomarker for monitoring chemotherapy resistance in small cell lung cancer patients treated with a first-line chemotherapy regimen
por: Zhang, Yang, et al.
Publicado: (2023)

CTCF promotes colorectal cancer cell proliferation and chemotherapy resistance to 5-FU via the P53-Hedgehog axis
por: Lai, Qiuhua, et al.
Publicado: (2020)

High-Fat Diet Affects Heavy Metal Accumulation and Toxicity to Mice Liver and Kidney Probably via Gut Microbiota
por: Liu, Ting, et al.
Publicado: (2020)

Irinotecan- vs oxaliplatin-based regimens for neoadjuvant chemotherapy in colorectal liver metastasis patients: A retrospective study
por: Liu, Wei, et al.
Publicado: (2022)

Treatment of intraoperatively detected peritoneal carcinomatosis of colorectal origin with cytoreductive surgery and intraperitoneal chemotherapy
por: Canda, Aras Emre, et al.
Publicado: (2018)

Hyperthermic Intraoperative Thoracoabdominal Chemotherapy
por: Sugarbaker, Paul H., et al.
Publicado: (2012)

Analysis of the Efficacy of Multidrug Combination Chemotherapy Regimens for Osteosarcoma and the Management of Chemotherapeutic Reactions
por: Tian, Dawei, et al.
Publicado: (2022)

Cost-minimization analysis of adjuvant chemotherapy regimens given to patients with colorectal cancer in Japan
por: Takata, Kosuke, et al.
Publicado: (2016)

Therapeutic Effect of CAOLD Chemotherapy Regimen on Patients With Relapsed/Refractory Angioimmunoblastic T-Cell Lymphoma: A Case Study
por: Liu, Yu, et al.
Publicado: (2022)

MAID chemotherapy regimen as a treatment strategy for metastatic malignant ameloblastoma: A case report
por: Li, Danyang, et al.
Publicado: (2019)

Incidence of venous thromboembolism following the neoadjuvant chemotherapy regimen for epithelial type of ovarian cancer
por: Chavan, Devendra Manik, et al.
Publicado: (2017)

Anti-EGFR therapy in metastatic colorectal cancer: mechanisms and potential regimens of drug resistance
por: Li, Qing-Hai, et al.
Publicado: (2020)

5-Fu-Based Doublet Regimen in Patients Receiving Perioperative or Postoperative Chemotherapy for Locally Advanced Gastric Cancer: When to Start and How Long Should the Regimen Last?
por: Liu, Zining, et al.
Publicado: (2021)

Clinical Efficacy of Chemotherapy Regimen Combined with Levofloxacin in Patients with Pulmonary Tuberculosis Complicated with Type-2 Diabetes
por: Luo, Pei-pei, et al.
Publicado: (2023)

Application of Bevacizumab Combined With Chemotherapy in Patients With Colorectal Cancer and Its Effects on Brain-Gut Peptides, Intestinal Flora, and Oxidative Stress
por: Chen, Chao, et al.
Publicado: (2022)

Sodium nitroprusside protects HFD induced gut dysfunction via activating AMPKα/SIRT1 signaling
por: Li, Xiaomei, et al.
Publicado: (2021)

Exploration of chemotherapy-free regimen after multi-line chemotherapy-induced renal impairment in recurrent ovarian cancer: Case report and literature review
por: Zhang, Liu-ping, et al.
Publicado: (2023)

Increasing Embryonic Morphogen Nodal Expression Suggests Malignant Transformation in Colorectal Lesions and as a Potential Marker for CMS4 Subtype of Colorectal Cancer
por: Wang, Xiaopai, et al.
Publicado: (2021)

Functional changes of the prefrontal cortex, insula, caudate and associated cognitive impairment (chemobrain) in NSCLC patients receiving different chemotherapy regimen
por: Liu, Siwen, et al.
Publicado: (2022)

Comparison of efficacy in adjuvant chemotherapy regimens in patients with radically resected gastric cancer: a propensity-matched analysis
por: Quan, RenCui, et al.
Publicado: (2016)

DCF intraperitoneal and intravenous dual chemotherapy regimen for advanced gastric cancer: A feasibility study
por: FENG, ZENG-LI, et al.
Publicado: (2015)

Mechanisms of chemotherapeutic resistance and the application of targeted nanoparticles for enhanced chemotherapy in colorectal cancer
por: Guo, Yu, et al.
Publicado: (2022)

Real-world cost analysis of chemotherapy for colorectal cancer in Japan: detailed costs of various regimens during the entire course of chemotherapy
por: Yajima, Shuichi, et al.
Publicado: (2016)

Comparative effectiveness of different chemotherapy regimens of advanced-stage Hodgkin lymphoma in adults: a network meta-analysis
por: Zhang, Tingting, et al.
Publicado: (2018)

Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein–Barr virus DNA level
por: Liu, Sai-Lan, et al.
Publicado: (2020)

PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer
por: Wang, Qiang, et al.
Publicado: (2018)

Optimizing induction chemotherapy regimens for radiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
por: Li, Ying, et al.
Publicado: (2023)

Changing monoclonal antibody keeping unaltered the chemotherapy regimen in metastatic colorectal cancer patients: is efficacy maintained?
por: Grande, Roberta, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_at8hsk49hf1jkvakafoe4o6h2r